Read + Share
Amedeo Smart
Independent Medical Education
Qu XM, Chen Y, Zaric GS, Senan S, et al. Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial. Int J Radiat Oncol Biol Phys 2021;109:1176-1184.PMID: 33309977
Email
LinkedIn
Facebook
Twitter
Privacy Policy